Upstream Bio (UPB) Accumulated Expenses (2023 - 2026)

Upstream Bio's Accumulated Expenses history runs 4 years deep, the most recent figure standing at $11.2 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 171.31% year-over-year to $11.2 million; the TTM figure through Mar 2026 stood at $11.2 million (up 171.31% YoY), while the FY2025 annual figure was $4.2 million, down 30.04% from the prior year.
• Accumulated Expenses was $11.2 million for Q1 2026 at Upstream Bio, up from $4.2 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $11.2 million in Q1 2026 to a low of $1.9 million in Q2 2025.
• Historically, Accumulated Expenses has averaged $5.6 million across 4 years, with a median of $4.9 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Accumulated Expenses tumbled 30.04% in 2025, then surged 171.31% in 2026.
• A 4-year view of Accumulated Expenses shows it stood at $4.5 million in 2023, then jumped by 33.75% to $6.0 million in 2024, then slumped by 30.04% to $4.2 million in 2025, then soared by 168.01% to $11.2 million in 2026.
• The last three Accumulated Expenses figures came in at $11.2 million (Q1 2026), $4.2 million (Q4 2025), and $7.2 million (Q3 2025), per Business Quant data.